• Keine Ergebnisse gefunden

The examination of the effects of Beta Amyloid on cultured primary cortical neurons

N/A
N/A
Protected

Academic year: 2022

Aktie "The examination of the effects of Beta Amyloid on cultured primary cortical neurons "

Copied!
2
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

The examination of the effects of Beta Amyloid on cultured primary cortical neurons

Selma Yilmazer1, Erdinç Dursun1, Duygu Gezen-Ak1

1. Istanbul University, Cerrahpasa Faculty of Medicine, Department of Medical Biology selmayilmazer@mynet.com

Keywords: Alzheimer’s disease, iNOS, beta amyloid Background:

Amyloid plaques that has amyloid beta peptide as a core component, are one of the major pathological hallmarks of Alzheimer’s disease. Induction of oxidative stress by amyloid plaques has been reported. On the other hand, the levels of inducible nitric oxide synthase (iNOS) shown to be elevated by oxidative stress (1,2,3). In this study our aim was to determine the effects of beta amyloid 1-42 treatment on iNOS expression in primary cortical neuron cultures.

Methods:

Cerebral cortex dissected from brains of Sprague Dawley rat embryos on the embryonic day 16 and cultured. The groups including 48 hours of beta amyloid 1-42 treated group and control groups were established. mRNA isolation and cDNA synthesis performed.

The levels of iNOS expressions were determined by qRT-PCR. Localization of iNOS was identified by immunofluorescent labeling.

Results:

Amount of neural processes in beta amyloid treated groups was decreased compared to the untreated control group. Beta amyloid aggregates were observed on and around both neuron soma and neural processes. Moderate immunoreactivity of iNOS was observed in the cytoplasm and neural processes of cortical neurons. Expression of iNOS in beta amyloid 1-42 treated group was found increased when compared with control group.

Conclusions:

Relative elevation in the levels of iNOS expression by beta amyloid treatment in cortical neurons might indicate the potential role of beta amyloid to induce oxidative stress via regulation of iNOS expression.

1. Kim HC, Yamada K, Nitta A, et al. Immunocytochemical evidence that amyloid beta (1-42) impairs endogenous antioxidant systems in vivo. Neuroscience 119 (2003) 399–419.

2. Markesbery WR. Oxidative stress hypothesis in Alzheimer’s disease. Free Radic.

Biol. Med. 1997.23: 134–147.

3. Law A, Gauthier S, Quirion R. Say NO to Alzheimer’s disease: the putative links between nitric oxide and dementia of the Alzheimer’s type. Brain Res. Rev. 35 (2001) 73–96.

I6.P146 - 247 - MC2009

G. Kothleitner, M. Leisch (Eds.): MC2009, Vol. 1: Instrumentation and Methodology, DOI: 10.3217/978-3-85125-062-6-122, © Verlag der TU Graz 2009

(2)

MC2009 - 248 - I6.P146

G. Kothleitner, M. Leisch (Eds.): MC2009, Vol. 1: Instrumentation and Methodology, DOI: 10.3217/978-3-85125-062-6-122, © Verlag der TU Graz 2009

Referenzen

ÄHNLICHE DOKUMENTE

Die Wissenschaftler haben jetzt her- ausgefunden, dass das Protein eine wichtige Rolle im Fettstoffwechsel spielt: Amyloid beta 40 verhindert, dass Cholesterin in den Zellen

(2001) ‘Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer’s disease.’, Journal of Neuroscience..

Overexpression of α - synuclein WT and α -synuclein A30P mutant in the cortex of the 5XFAD mouse resulted in the development of α -synuclein positive Lewy-neurites, while no

The results showed that the microstructure influences the tribocorrosion properties of titanium alloys, where lower wear track volume, material loss and friction were observed on

Alzheimer’s disease (AD) is a deleterious neurodegenerative disorder with an increasing prevalence. Currently, there are neither reliable early diagnostic markers nor available

Here in Chapter 3, it is demonstrated, by a combination of solution-state and solid-state NMR spectroscopy, that the structure of amyloid fibrils of α-synuclein (αS) is

Intraneuronal beta-amyloid aggregates, neurodegener- ation, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid

Maiken Needergard, die das glymphati- sche System 2013 beschrieb, erklärte seine Funktionsweise damals so: «Das Hirn hat nur eine begrenzte Menge an Energie zur Verfügung, und es